Compare TransMedics Group Inc (TMDX) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs ProShares Ultra Gold ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while ProShares Ultra Gold ETF trades at $44.93. Which is the better fit depends on your goals.
| TMDX | UGL | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $150.42 | $85.62 |
52-Week Low | $61.99 | $33.59 |
Enterprise Value | $2.94B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
